Myeloproliferative Neoplasm — Trials

Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,033 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 964
Recruiting: 552
Ph III recruiting: 55
Growth YoY: +9.8%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (699)

clinicaltrialsPublishedShowing 51–100 of 178 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05330364	Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid Leukemia	unknown	Phase 2	31	Ge ZhengOTHER	1	Apr 29, 2022	clinicaltrials
NCT04764513	Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT	unknown	Phase 1 / Phase 2	20	Chinese PLA General HospitalOTHER	1	Mar 28, 2022	clinicaltrials